Skip navigation
中文
English
DSpace
CRIS
Home
Organizations
Researchers
Research Outputs
Explore by
Organizations
Researchers
Research Outputs
Academic & Publications
Help
中文
English
NTU Scholars
National Taiwan University
/
College of Medicine
/
Radiology
CHAO-YU HSU
Network Lab
View Statistics
Email Alert
RSS Feed
Information
Publications
49
Project
2
Publications
(All)
All
Articles
Review
Others
Show/Hide filters
Author
3
bang-bin chen
3
chih-hung hsu
3
chih-wei yu
3
tiffany ting-fang shih
2
chen b.-b.;hsu c.-y.;yu c.-w.;liang p.-c.;hsu c.;chih-hung hsu;cheng a.-l.;shih t.t.-f.
2
po-chin liang
1
hsu c.-y. ;shen y.-c. ;yu c.-w. ;hsu c. ;hu f.-c. ;chih-hung hsu ;chen b.-b. ;wei s.-y. ;cheng a.-l. ;shih t.t.-f.
1
hu f.-c.
1
wei s.-y.
1
ying-chun shen
.
next >
Subject
3
[sdgs]sdg3
1
gadodiamide; placebo; sorafenib; tegafur; uracil; vandetanib; antineoplastic agent; contrast medium; gadolinium pentetate; adult; advanced cancer; age; aged; cancer chemotherapy; cancer mortality; cancer prognosis; cancer survival; comparative study; controlled study; disease association; dynamic contrast-enhanced magnetic resonance imaging; female; gender; human; liver cell carcinoma; liver parenchyma; major clinical study; male; overall survival; phase 2 clinical trial (topic); portal vein thrombosis; priority journal; retrospective study; review; risk factor; survival time; systemic therapy; tumor volume; carcinoma, hepatocellular; diagnostic imaging; liver neoplasms; middle aged; nuclear magnetic resonance imaging; pathology; procedures; survival rate; treatment outcome; very elderly; adult; aged; aged, 80 and over; antineoplastic combined chemotherapy protocols; carcinoma, hepatocellular; contrast media; gadolinium dtpa; humans; liver neoplasms; magnetic resonance imaging; middle aged; retrospective studies; survival rate; treatment outcome
1
placebo; sorafenib; uft; vandetanib; contrast medium; adult; advanced cancer; aged; antiangiogenic activity; area under the curve; article; cancer chemotherapy; cancer patient; cancer prognosis; cancer survival; clinical outcome; controlled study; dynamic contrast-enhanced magnetic resonance imaging; fatality; female; human; image analysis; kaplan meier method; liver cell carcinoma; major clinical study; male; overall survival; perfusion; priority journal; retrospective study; systemic therapy; cancer staging; disease exacerbation; follow up; liver cell carcinoma; liver circulation; liver tumor; magnetic resonance angiography; middle aged; multimodality cancer therapy; physiology; predictive value; prevalence; procedures; survival rate; taiwan; time factor; trends; vascularization; very elderly; young adult; adult; aged; aged, 80 and over; carcinoma, hepatocellular; combined modality therapy; contrast media; disease progression; female; follow-up studies; humans; liver circulation; liver neoplasms; magnetic resonance angiography; male; middle aged; neoplasm staging; predictive value of tests; prevalence; survival rate; taiwan; time factors; young adult
1
sorafenib; uft; adult; aged; article; blood vessel reactivity; cancer survival; clinical article; dynamic contrast enhanced magnetic resonance imaging; female; human; liver cell carcinoma; male; nuclear magnetic resonance imaging; outcome assessment; overall survival; phase 2 clinical trial (topic); priority journal; progression free survival; survival rate; survival time; treatment response; adult; aged; aged, 80 and over; antimetabolites, antineoplastic; antineoplastic agents; antineoplastic combined chemotherapy protocols; benzenesulfonates; biological markers; carcinoma, hepatocellular; contrast media; feasibility studies; female; humans; liver neoplasms; magnetic resonance imaging; male; middle aged; neovascularization, pathologic; predictive value of tests; pyridines; tegafur; uracil; young adult
Date issued
1
2017
1
2016
1
2011
By type
2
journal article
1
review
Fulltext
3
no fulltext
Close filters
Refined By:
Author:
chao-yu hsu
Author:
ann-lii cheng
Author:
chiun hsu
Results 1-3 of 3 (Search time: 0.008 seconds).
Issue Date
Title
Author(s)
Source
scopus
WOS
Fulltext/Archive link
1
2017
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
BANG-BIN CHEN
; CHAO-YU HSU
; CHIH-WEI YU
; PO-CHIN LIANG
; CHIUN HSU
; CHIH-HUNG HSU
; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
European Radiology
15
17
2
2016
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
BANG-BIN CHEN
; CHAO-YU HSU
; CHIH-WEI YU
; PO-CHIN LIANG
; CHIUN HSU
; CHIH-HUNG HSU
; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
Radiology
27
25
3
2011
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
CHAO-YU HSU
; Ying-Chun Shen
; CHIH-WEI YU
; CHIUN HSU
; Hu F.-C.; CHIH-HUNG HSU
; BANG-BIN CHEN
; Wei S.-Y.; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
Journal of Hepatology
106
100
Claim Researcher Page
Login via ORCID to claim this profile:
ORCID Login
Contact via feedback form
If you want contact administrator site clicking the follow button